Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization-Reference-Cited by-同舟云学术

Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization

Published:2017-05-22 Issue:1 Volume:3 Page:
ISSN:2059-1381
Container-title:Renal Replacement Therapy
language:en
Short-container-title:Ren Replace Ther

Author:

Kawano Tomoyuki,Kuji Tadashi,Fujikawa Tetsuya,Ueda Eiko,Shino Midori,Yamaguchi Satoshi,Ohnishi Toshimasa,Tamura Kouichi,Hirawa Nobuhito,Toya Yoshiyuki

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s41100-017-0103-1.pdf

Reference23 articles.

1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53–61.

2. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987;316:73–8.

3. López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008;111:S75–81.

4. Fujikawa T, Ikeda Y, Fukuhara S, Akiba T, Akizawa T, Kurokawa K, Saito A. Time-dependent resistance to erythropoiesis-stimulating agent and mortality in hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract. 2012;122(1-2):24–32.

5. Richardson D. Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant. 2002;l7(Suppl):53–9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease;Journal of Clinical Medicine;2023-06-22

2. Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD;Kidney360;2022-09-29

3. Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume;Renal Replacement Therapy;2021-02-17